Vicore Pharma Holding AB
NASDAQ:VCREMedical - Pharmaceuticals
-$0.24 today
- Market cap
- $279.65M
- Beta
- 0.15
Volume 0.00M
Average 0.26M
Balance Sheet
Inspect the capital base behind the business.
Assets
$1.22B
FY 2025 · Annual
Liabilities
$123.17M
FY 2025 · Annual
Equity
$1.10B
FY 2025 · Annual
Balance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $44.2M |
| Short-term Investments | $49.2M |
| Other Current | $2.1M |
| Total Current Assets | $95.5M |
| Other Non-current | $388.7K |
| Total Non-current Assets | $388.7K |
| Total Assets | $95.9M |
Analysis
Selected assets total $95.9M for Latest. The largest visible component is Short-term Investments at $49.2M, about 51.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 5, 2026 | |
| 6-K | 6-K filing | Nov 3, 2026 | |
| 6-K | 6-K filing | Oct 22, 2026 | |
| SC 13G | SC 13G filing | Oct 13, 2026 | |
| 6-K | 6-K filing | Sep 30, 2026 |
How much cash does VCRE have?
Vicore Pharma Holding AB (VCRE) reported $578.15M in cash and equivalents in fiscal 2025.
How much debt does VCRE carry?
Vicore Pharma Holding AB (VCRE) reported $0.00 of total debt, with net debt of -$578.15M.
Continue the stock analysis
Jump to another research area for this company.